ideavilla.blogg.se

Cola cytoscape alignment
Cola cytoscape alignment











cola cytoscape alignment

If you have more than one, please ask your most pressing question first and then re-enter the queue. In addition, this call may contain forward-looking statements, including statements concerning long-term earnings objectives, which should be considered in conjunction with cautionary statements contained in our earnings release and in the company's periodic SEC reports.įollowing prepared remarks, we will turn the call over for questions. You can also find schedules in the same section of our website that provide an analysis of our gross and operating margins. These schedules reconcile certain non-GAAP financial measures which may be referred to by our senior executives during this morning's discussion to our results, as reported under Generally Accepted Accounting Principles. We've posted schedules under Financial Information in the Investors section of our company website at. I'm here with James Quincey, our Chairman and Chief Executive Officer and John Murphy, our President and Chief Financial Officer. Good morning, and thank you for joining us. Robin Halpern, Vice President and Head of Investor Relations. Media participants should contact Coca-Cola's Media Relations Department if they have any questions. I would like to remind everyone that the purpose of this conference is to talk with investors and therefore questions from the media will not be addressed. All participants will be in a listen-only mode until the formal question-and-answer portion of the call. If you have any objections, please disconnect at this time. John Murphy - President and Chief Financial OfficerĪt this time, I'd like to welcome everyone to the Coca-Cola Company's Second Quarter 2023 Earnings Results Conference Call.

cola cytoscape alignment

James Quincey - Chairman and Chief Executive Officer Robin Halpern - Vice President and Head of Investor Relations The Coca-Cola Company ( NYSE: KO) Q2 2023 Earnings Conference Call J8:30 AM ET













Cola cytoscape alignment